Literature DB >> 18085359

The effect of Nomega-nitro-L-arginine methyl ester and L-arginine on lung injury induced by abdominal aortic occlusion-reperfusion.

Huseyin Okutan1, Ilker Kiris, Ali K Adiloglu, Cagri Savas, Nilgün Kapucuoğlu, Irfan Altuntas, Onur Akturk.   

Abstract

PURPOSE: The aim of this study was to examine the effects of Nomega-nitro-L-arginine methyl ester (L-NAME) and L-arginine on lung injury after aortic ischemia-reperfusion (IR).
METHODS: Twenty-four Wistar-Albino rats were randomized into four groups (n = 6) as follows: Control (sham laparotomy), Aortic IR (30 min ischemia and 120 min reperfusion), L-Arginine (intraperitoneal 100 mg kg(-1) live weight)+aortic IR, and L: -NAME (intraperitoneal 10 mg kg(-1) live weight)+aortic IR. In the lung specimens, the tissue levels of malondialdehyde (MDA), vascular endothelial growth factor (VEGF), and nitric oxide (NO) were measured and a histological examination was done.
RESULTS: Aortic IR increased MDA, VEGF, and NO. L-Arginine further significantly increased MDA and NO, and decreased VEGF (P < 0.05 vs aortic IR). L-NAME significantly decreased MDA and NO (P < 0.05 vs L-arginine+aortic IR) and increased VEGF (P < 0.05 vs other groups). A histological examination showed the aortic IR to significantly increase (P < 0.05 vs control) while L-arginine also further increased (P > 0.05 vs aortic IR), whereas L-NAME caused a significant decrease in pulmonary leukocyte infiltration (P < 0.05 vs aortic IR).
CONCLUSIONS: Our results indicate that L-arginine aggravates the lung injury induced by aortic IR, while L-NAME attenuates it.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085359     DOI: 10.1007/s00595-007-3575-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  46 in total

1.  A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo.

Authors:  Shastri Sookhai; Jiang Juai Wang; Morgan McCourt; William Kirwan; David Bouchier-Hayes; Paul Redmond
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

Review 2.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 3.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

Review 4.  The pathophysiology of aortic cross-clamping and unclamping.

Authors:  S Gelman
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

5.  Aneurysmal and occlusive atherosclerosis of the human abdominal aorta.

Authors:  C Xu; C K Zarins; S Glagov
Journal:  J Vasc Surg       Date:  2001-01       Impact factor: 4.268

6.  In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys.

Authors:  P Eschwège; V Paradis; M Conti; A Holstege; F Richet; J Detève; P Ménager; A Legrand; A Jardin; P Bedossa; G Benoit
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

7.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

Authors:  R M Tuder; B E Flook; N F Voelkel
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 8.  Vascular endothelial growth factor and related molecules in acute lung injury.

Authors:  Marco Mura; Claudia C dos Santos; Duncan Stewart; Mingyao Liu
Journal:  J Appl Physiol (1985)       Date:  2004-11

9.  The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit.

Authors:  G R May; P Crook; P K Moore; C P Page
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival.

Authors:  Marco Mura; Bing Han; Cristiano F Andrade; Rashmi Seth; David Hwang; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.